ID TYRA_STAS1 Reviewed; 363 AA. AC Q49XG5; DT 03-APR-2007, integrated into UniProtKB/Swiss-Prot. DT 13-SEP-2005, sequence version 1. DT 27-MAR-2024, entry version 109. DE RecName: Full=Prephenate dehydrogenase; DE Short=PDH; DE EC=1.3.1.12; GN Name=tyrA; OrderedLocusNames=SSP1387; OS Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM OS 20229 / NCIMB 8711 / NCTC 7292 / S-41). OC Bacteria; Bacillota; Bacilli; Bacillales; Staphylococcaceae; OC Staphylococcus. OX NCBI_TaxID=342451; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 15305 / DSM 20229 / NCIMB 8711 / NCTC 7292 / S-41; RX PubMed=16135568; DOI=10.1073/pnas.0502950102; RA Kuroda M., Yamashita A., Hirakawa H., Kumano M., Morikawa K., Higashide M., RA Maruyama A., Inose Y., Matoba K., Toh H., Kuhara S., Hattori M., Ohta T.; RT "Whole genome sequence of Staphylococcus saprophyticus reveals the RT pathogenesis of uncomplicated urinary tract infection."; RL Proc. Natl. Acad. Sci. U.S.A. 102:13272-13277(2005). CC -!- CATALYTIC ACTIVITY: CC Reaction=NAD(+) + prephenate = 3-(4-hydroxyphenyl)pyruvate + CO2 + CC NADH; Xref=Rhea:RHEA:13869, ChEBI:CHEBI:16526, ChEBI:CHEBI:29934, CC ChEBI:CHEBI:36242, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.3.1.12; CC -!- PATHWAY: Amino-acid biosynthesis; L-tyrosine biosynthesis; (4- CC hydroxyphenyl)pyruvate from prephenate (NAD(+) route): step 1/1. CC -!- SIMILARITY: Belongs to the prephenate/arogenate dehydrogenase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AP008934; BAE18532.1; -; Genomic_DNA. DR RefSeq; WP_002483353.1; NZ_MTGA01000038.1. DR AlphaFoldDB; Q49XG5; -. DR SMR; Q49XG5; -. DR GeneID; 66867610; -. DR KEGG; ssp:SSP1387; -. DR eggNOG; COG0287; Bacteria. DR HOGENOM; CLU_055968_2_1_9; -. DR OrthoDB; 9802008at2; -. DR UniPathway; UPA00122; UER00961. DR Proteomes; UP000006371; Chromosome. DR GO; GO:0070403; F:NAD+ binding; IEA:InterPro. DR GO; GO:0008977; F:prephenate dehydrogenase (NAD+) activity; IEA:UniProtKB-EC. DR GO; GO:0004665; F:prephenate dehydrogenase (NADP+) activity; IEA:InterPro. DR GO; GO:0006571; P:tyrosine biosynthetic process; IEA:UniProtKB-UniPathway. DR CDD; cd04909; ACT_PDH-BS; 1. DR Gene3D; 3.30.70.260; -; 1. DR Gene3D; 1.10.3660.10; 6-phosphogluconate dehydrogenase C-terminal like domain; 1. DR Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1. DR InterPro; IPR008927; 6-PGluconate_DH-like_C_sf. DR InterPro; IPR045865; ACT-like_dom_sf. DR InterPro; IPR002912; ACT_dom. DR InterPro; IPR036291; NAD(P)-bd_dom_sf. DR InterPro; IPR046825; PDH_C. DR InterPro; IPR046826; PDH_N. DR InterPro; IPR003099; Prephen_DH. DR PANTHER; PTHR21363; PREPHENATE DEHYDROGENASE; 1. DR PANTHER; PTHR21363:SF0; PREPHENATE DEHYDROGENASE [NADP(+)]; 1. DR Pfam; PF01842; ACT; 1. DR Pfam; PF20463; PDH_C; 1. DR Pfam; PF02153; PDH_N; 1. DR SUPFAM; SSF48179; 6-phosphogluconate dehydrogenase C-terminal domain-like; 1. DR SUPFAM; SSF55021; ACT-like; 1. DR SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1. DR PROSITE; PS51671; ACT; 1. DR PROSITE; PS51176; PDH_ADH; 1. PE 3: Inferred from homology; KW Amino-acid biosynthesis; Aromatic amino acid biosynthesis; NAD; KW Oxidoreductase; Reference proteome; Tyrosine biosynthesis. FT CHAIN 1..363 FT /note="Prephenate dehydrogenase" FT /id="PRO_0000282666" FT DOMAIN 2..291 FT /note="Prephenate/arogenate dehydrogenase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00522" FT DOMAIN 296..363 FT /note="ACT" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01007" FT BINDING 3..33 FT /ligand="NAD(+)" FT /ligand_id="ChEBI:CHEBI:57540" FT /evidence="ECO:0000255" SQ SEQUENCE 363 AA; 40963 MW; 130EB5895E8F90DF CRC64; MKQILFVGLG LIGGSLASNL RYYHDDIEIT AFDADTSQLD KALSIGIIDY QSTDYKTSVE NADIIIYATP VQQTVKYLQD LPNYQLKKHV IITDTGSTKS TIQQYEQFLL NHDIHLVGGH PMAGSHKSGV LNAKKHLFEN AFYILVHNET DNDAAFEEIQ HLLQTTSAKF ISTTAEEHDF VTGIVSHVPH IIASSLVHLN AQHVEDSSLV KTLAAGGFRD ITRIASSNPI MWRDITIENK NTILRILKEW KNQMSDVINI IEHNNPDELY DFFNDAKVYR DQLPLKQQGA LSVEYDLYVD IPDKPGMISK VTNILSLHNI SISNLRILEV REDIYGALRV SFKNPQDRKD GADALSDFDT YFD //